Table 1.

Change in Second-Order Rate Constants of fXa Inhibition

Active Formα-Antithrombinβ-Antithrombin
− Heparin (mmol/L−1s−1)+ Heparin (mmol/L−1s−1)− Heparin (mmol/L−1s−1)+ Heparin (mmol/L−1s−1)L:β, 10:1 (mmol/L−1s−1)10:1, + Heparin (mmol/L−1s−1)
(as) Monomer 3.75 ± 0.01 2,170 ± 190 7.16 ± 0.15 2,410 ± 180 7.16 ± 0.15 2,410 ± 180 
(in) Dimer 3.34 ± 0.08 1,720 ± 160 5.65 ± 0.05 1,630 ± 130 3.79 ± 0.15 843 ± 33 
Activity loss 11% 21% 21% 33% 47% 65% 
Active Formα-Antithrombinβ-Antithrombin
− Heparin (mmol/L−1s−1)+ Heparin (mmol/L−1s−1)− Heparin (mmol/L−1s−1)+ Heparin (mmol/L−1s−1)L:β, 10:1 (mmol/L−1s−1)10:1, + Heparin (mmol/L−1s−1)
(as) Monomer 3.75 ± 0.01 2,170 ± 190 7.16 ± 0.15 2,410 ± 180 7.16 ± 0.15 2,410 ± 180 
(in) Dimer 3.34 ± 0.08 1,720 ± 160 5.65 ± 0.05 1,630 ± 130 3.79 ± 0.15 843 ± 33 
Activity loss 11% 21% 21% 33% 47% 65% 

or Create an Account

Close Modal
Close Modal